Status:
COMPLETED
COVID-19 Vaccines Associated Malaise
Lead Sponsor:
University Hospital, Caen
Conditions:
Vaccine Adverse Reaction
Eligibility:
All Genders
Brief Summary
COVID-19 vaccines induced malaise have recently been reported in the literature. Our study aims to identify risk factors associated with the onset of COVID-19 vaccines induced malaise and to assess if...
Eligibility Criteria
Inclusion
- all adverse events reported in the WHO pharmacovigilance database
Exclusion
- none
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 26 2022
Estimated Enrollment :
1534706 Patients enrolled
Trial Details
Trial ID
NCT05234333
Start Date
January 1 2021
End Date
January 26 2022
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital, Department of Pharmacology
Caen, Normandy, France, 14033